Skip to main
HUM
HUM logo

Humana (HUM) Stock Forecast & Price Target

Humana (HUM) Analyst Ratings

Based on 17 analyst ratings
Hold
Strong Buy 6%
Buy 29%
Hold 65%
Sell 0%
Strong Sell 0%

Bulls say

Humana has revised its earnings per share (EPS) estimate for 2025 to $17.06, a notable increase from the previous estimate of $16.26, driven by solid second-quarter results and updated guidance. The company anticipates year-over-year earnings growth in 2027 as margin improvement initiatives take effect, despite the expectation that the Stars rating will remain stable and not contribute to bonus payments. Additionally, Humana has demonstrated a strong commitment to sustainability, achieving over a 20% reduction in greenhouse gas emissions since 2017, which reflects positively on its operational efficiency and corporate responsibility.

Bears say

Humana's management anticipates a slight decline in 2026 earnings per share (EPS) compared to 2025 due to challenges from the Stars program, which may partially be mitigated by margin initiatives. In a downside scenario, there is a projection that fiscal year 2027 EPS could fall approximately 10% below estimates as the company plans to increase investments aimed at supporting the recovery of the Stars program. Additionally, despite potential benefit cuts by competitors, management believes a benefit gap will persist, indicating ongoing pressure within the competitive landscape.

Humana (HUM) has been analyzed by 17 analysts, with a consensus rating of Hold. 6% of analysts recommend a Strong Buy, 29% recommend Buy, 65% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Humana (HUM) Forecast

Analysts have given Humana (HUM) a Hold based on their latest research and market trends.

According to 17 analysts, Humana (HUM) has a Hold consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $296.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $296.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Humana (HUM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.